跳至主要内容
临床试验/ISRCTN14347002
ISRCTN14347002
已完成
未知

The regenerative surgical treatment of intra-bony peri-implantitis defects with Endobon® (test) versus an established bovine derived bone mineral (control) – a pilot study

Academic Center for Dentistry Amsterdam0 个研究点目标入组 25 人2020年2月20日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
Academic Center for Dentistry Amsterdam
入组人数
25
状态
已完成
最后更新
5年前

概览

简要总结

2020 results in https://doi.org/10.1111/clr.13651 (added 11/09/2020)

注册库
who.int
开始日期
2020年2月20日
结束日期
2019年5月16日
最后更新
5年前
研究类型
Interventional
性别
All

研究者

发起方
Academic Center for Dentistry Amsterdam

入排标准

入选标准

  • 1\. During surgical exploration an intra\-bony component of at least 3 mm at the deepest point must be present.
  • 2\. The defect should have a minimum of 3 osseous walls (a circumference of the osseous defect of at least 270 degrees). Only 3 and 4 wall intraosseous defects will be included
  • 3\. The defect must not be wider than 4 mm and the defect angle must be less than 35 degrees from axis of implant
  • Note: If the same patient has more than one defect meeting the inclusion criteria only one such defect will be included in the study and the other defects will be treated with standard open flap debridement

排除标准

  • 1\. Diabetes mellitus (HbAlc \= 6\.5%)
  • 2\. Taking corticosteroids or other anti\-inflammatory prescription drug
  • 3\. Taking medications known to induce gingival hyperplasia
  • 4\. Allergic to penicillin or metronidazole
  • 5\. History of taking systemic antibiotics in the preceding month
  • 6\. Pregnant or lactating
  • 7\. Stability of the Endobon® granules or control granules cannot be accomplished in the defect
  • 8\. Failure of obtaining soft tissue closure
  • 9\. Mobile implants

结局指标

主要结局

未指定

相似试验